Abstract
It is now more than two decades since the AIDS epidemic began with a cluster ofPneumocystiscarinii pneumonia (PCP) in a community of homosexual men. Since then, many other infections have been characterized as opportunistic infections secondary to HIV infection. These include, but are not limited to, infections withToxoplasma gondii, Cytomegalovirus (CMV),Mycobacterium avium complex (MAC), andCryptococcus neoformans. Over the last two decades, there have been dramatic improvements in diagnosis, prevention and treatment of all these infections. As a result, in North America and Western Europe the rates of opportunistic infections secondary to AIDS have decreased substantially. We will review these common opportunistic infections below.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anderson, K. P., Atlas, E., Ahern, M. J. and Weisbrot, I. M., Central nervous system toxoplasmosis in homosexual men.Am. J. Med., 75, 877–881 (1983).
Antinori, A., Ammasasri, A., De Luca, A., Cingolani, A., Murri, R., Scoppettuolo, G., Fortini, M., Tartaglione, T., Larocca, L. M., Zannoni, G., Cattani, P., Grillo, R., Roselli, R., lacoangeli, M., Scerrati, M. and Ortona, L., Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiologic characteristics combined with porpu ase chain reaction assays in CSF.Neurologv 48, 687–694 (1997).
Arribas, J. R., Clifford, D. B., Fichtenbaum, C. J., Commons, D. L., Powderly, W. G. and Storch, G. A., Level of Cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.J. Infect. Dis., 172, 527–531 (1995).
Arribas, J. R., Storch, G. A., Clifford, D. B., and Tselis, A.C., Cytomegalovirus encephalitis.Ann.Intern. Med., 125, 577–587 (1996).
Baril, L., Jouan, M., Agher, R., Cambau, E., Caumes, E., Bricaire, F. and Katlama, C., Impact of highly active antiretroviral therapy on onset ofMycobacterium avium complex infection and Cytomegalovirus disease in patients with AIDS.AIDS, 14, 2593–2596 (2000).
Beaugerie, L., Cywiner-Golenzer, C., Monfort, L., Girard, P. M., Carbonnel, F., Ngo, Y., Cosnes, J., Rozenbaum, W., Nicolas, J. C., Chatelet, F. P. and Gendre, J.P., Definition and diagnosis of Cytomegalovirus colitis in patients infected by human immunodeficiency virus.J. Acquir. Immune. Defic. Syndr., 14, 423–429 (1997).
Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., McGee, Z. A., Cate, T. R., Cobbs, C. G., Warner, J. F. and Ailing, D.W., A comparison of amphotericin B alone and combined with flucytosine in treatment of cryptococcal meningitis.N. Engl. J. Med., 301, 126–131 (1979).
Benson, C. A.,Mycobacterium avium complex and other atypical mycobacterial infections. In Dolin R., Masur H., and Saag M. S. (ed),AIDS Therapy. Churchill Livingstone, Philadelphia. pp 375–390 (1999).
Benson, C. A., Disease due to theMycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome.Clin. Infect. Dis., 18(Suppl 3), S218–222 (1994).
Benson, C. A., Disseminated MAC infection: implications of recent clinical trials on prophylaxis and treatment.AIDS Clinical Review, 271-287 (1997–1998).
Blanshard, C., Benhamou, Y., Dohin, E., Lernestedt, J. O., Gazzard, B. G. and Katlama, C., Treatment of AIDS- associated gastrointestinal Cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.J. Infect. Dis., 172, 622–628 (1995).
Bozette, S. A., Finkelstein, D. M., Spector, S. A., Frame, P., Powderly, W. G., He, W., Phillips, L., Craven, D., Van Der Horst, C. and Feinberg, J. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection.N. Engl. J. Med., 332, 693–699 (1995).
Bozette, S. A., Larsen, R. A., Chiu, J., Leal, M. A., Jacobsen, J., Rothman, P., Robinson, P., Gilbert, G., McCutchan, J. A. and Tilles, J., for the California Collaborative Treatment Group, A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.N. Engl. J. Med., 324, 580–584 (1991).
Bustamante, E. A. and Levy, H. Sputum induction compared with bronchoalveolar lavage by Ballard catheter to diagnose Pneumocystis carinii pneumonia.Chest, 105, 816–822 (1994).
Carr, A., Tindall, B., Brew, B. J., Marriott, D. J., Harkness, J. L., Perry, R. and Cooper, D.A., Low dose trimethoprim- sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.Ann. Intern. Med., 117, 106–111 (1992).
Centers for Disease Control task force on Kaposis sarcoma and opportunistic infections: epidemiologic aspects of the current outbreak of Kaposis sarcoma and opportunistic infections.N. Engl. J. Med., 306, 248–252 (1982).
Chaisson, R. E., Moore, R. D., Richman, D. D., Keruly, J., Creagh, T., and the zidovudine epidemiology study group, incidence and natural history ofMycobacterium avium complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine.Am. Rev. Respir. Dis., 146, 285–289 (1992).
Chaisson, R. E., Benson, C. A., Dube, M. P., Heifets, L. B., Korvick, J. A., Elkin, S., Smith, T., Craft, J. C., Sattler, F. R., and the AIDS Clinical Trials Group Protocol 157 Study Team, clarithromycin therapy for bacteremicMycobacterium avium complex disease.Ann. Intern. Med., 121, 905–911 (1994).
Chin, D. P., Reingold, A. L., Stone, E. N., Vittinghoff, E., Horsburgh, C. R., Simon, E. M., Yajko, D. M., Hadley, W. K., Ostroff, S. M. and Hopewell, PC. The impact ofMycobacterium avium complex bacteremia and its treatment on survival of AIDS patientsa prospective study.J. Infect. Dis., 170, 578–584 (1994).
Chuck, S. L. and Sande, M. A., Infections withCryptococcus neoformans in the acquired immunodeficiency syndrome.N. Engl. J. Med., 321, 794–799 (1989).
Collier, A. C., Meyers, J. D., Corey, L., Murphy, V. L., Roberts, P. L. and Handsfield, H. H., Cytomegalovirus infection in homosexual men: relationship to sexual practices, antibody to human immunodeficiency virus, and cell mediated immunity.Am. J. Med., 23, 593–601 (1987).
Cox, G. M., and Perfect, J. R., AIDS-associated cryptococcal meningoencephalitis, UpToDate www.uptodate.com (2000).
Currier, J. S., Williams, P. L., Koletar, S. L., Cohn, S. E., Murphy, R. L., Heald, A. E., Hafner, R., Basily, E. L., Lederman, H. M., Knirsch, C., Benson, C. A., Valdez, H., Aberg, J. A., and McCutchan, J. A., for the AIDS Clinical Trials Group 362 Study Team, discontinuation ofMycobacterium avium complex prophylaxis in patients with antiretroviral therapyinduced increases in CD4+ cell count.Ann. Int. Med., 133, 493–503 (2000).
Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussblum, J., Clumeck, N., Morlat, P. and Chiu, J., Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.Ann. Intern. Med., 116, 33–43 (1992).
Davaro, R. E., and Himlan, P., Immune Restoration Disorders Following HAART.The AIDS Reader, 9, 167–169 (1999).
De Lorenzo, L. J., Huang, C. T., Maguire, G. P. and Stover, D. E., Roentgenographic patterns ofPneumocystis carinii pneumonia in 104 patients with AIDS.Chest, 91, 323–327 (1987).
DeSimone, J., Pomerantz, R. J., and Babinchak, T. J., Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.Ann. Intern. Med., 133, 447–454 (2000).
Detels, R., Munoz, A., McFarlane, G., Kingsley, L. A., Margolick, J. B., Giorgi, J., Schrager, L. K. and Phair, J. P., for the Multicenter AIDS Cohort Study investigators, effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration.JAMA, 280, 1497–1503 (1998).
Detels, R., Tarwater, P., Phair, J. P., Margolick, J., Riddler, S. A. and Munoz, A., for the Multicenter AIDS Cohort Study, effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis.AIDS, 15, 347–355 (2001).
Diamond, R. D.,Cryptococcus neoformans, inPrinciples and Practice of Infectious Diseases, Mandell, G. L., Bennett, J. E., and Dolin, R., Churchill Livingstone, Philadelphia, pp 2707–2718 (2000).
Dieterich, D. T., Kotler, D. P., Busch, D. F., Crumpacker, C., Du Mond, C., Dearmand, D. and Buhles, W., Ganciclovir treatment of Cytomegalovirus colitis in AIDS: a randomized double-blind, placebo controlled multicenter study.J. Infect. Dis., 167, 278–282 (1993).
Dismukes, W. E., Cloud, G., Gallis, H. A., Kerkering, T. M., Medoff, G., Craven, P. C., Kaplowitz, L. G., Fisher, J. F., Gregg, C. R. and Bowles, C. A. for the Mycosis Study Group, Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.N. Engl. J. Med., 317, 334–341 (1987).
Dohn, M. N., Weinberg, W. G., Torres, R. A., Follansbee, S. E., Caldwell, P. T., Scott, J. D., Gathe, J. C., Haghighat, D. P., Sampson, J. H., Spotkov, J., Derensinski, S. C., Meyer, R. D. and Lancaster, D.J., Oral atovaquone compared with intravenous pentamadine forPneumocystis carinii pneumonia in patients with AIDS.Ann. Intern. Med., 121, 174–180 (1994).
El-Sadr, W. M., Burman, W. J., Grant, L. B., Marts, J. P., Hafner, R., Crane, L., Zeh, D., Gallagher, B., Mannheimer, S. B., Martinez, A., and Gordin, F., for the Terry Beirn Community Programs for Clinical Research on AIDS, discontinuation of prophylaxis againstMycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy.N. Engl. J. Med., 342, 1085–1092 (2000).
Fitzpatrick, T. B., Johnson, R. A., Polano, M. K., Suurmond, D. and Wolff, K., Cryptococcosis, InColor Atlas and Synopsis of Clinical Dermatology. McGraw-Hill, New York pp. 326–327 (1992).
Follansbee, S. E., Busch, D. F., Wofsy, C. B., Coleman, D. L., Gullet, J., Auregemma, G. P., Ross, T., Hadley, W. K. and Drew, W. L. An outbreak ofPneumocystis carinii pneumonia in homosexual men.Ann. Intern. Med., 96, 705–713 (1982).
Fox, J. D., Brink, N. S., Zuckerman, M. A., Neild, P., Gazzard, B. G., Tedder, R. S. and Miller, R. F., Detection of herpes virus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation.J. Infect. Dis., 172, 1087–1090 (1995).
Freeman, W. R., Friedberg, D. N., Berry, C., Quiceno, J. I., Behette, M., Fullerton, S. C. and Munguia, D., Risk factors for development of rhegmatogenous retinal detachment in patients with Cytomegalovirus retinitis.Am. J. Ophthalmol., 116, 713–720 (1993).
French, M. A. H., Antiretroviral therapy immune restoration disease in HIV-infected patients on HAART. TheAIDS Reader, 9, 548–562 (1999).
Furrer, H., Oppravil, M., Bernasconi, E., Telenti, A., and Egger, M., Stopping primary prophylaxis in HIV-1 infected patients at high risk of Toxoplasma encephalitis. Swiss HIV Cohort Study.Lancet, 355, 2217–2218 (2000).
Gagnon, S., Boota, A. M., Fischl, M. A., Baier, H., Kirskey, O. W. and La Voie, L., Corticosteroids as adjunctive therapy for severePneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double blind placebo controlled trial.N. Engl. J. Med., 323, 1444–1450 (1990).
Gallant, J. E., Moore, R., Richman, D. D., Keruly, J., Chaisson, R. E., and the zidovudine Epidemiology study group, Incidence and natural history of Cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine.J. Infect. Dis., 166, 1223–1227 (1992).
Garofano, S., Cryptococcal pulmonary infections in AIDS, UpToDatewww.uptodate.com (1998).
Girard, P. M., Landman, R., Gaudebout, C., Olivares, R., Saimot, A. G., Jelazko, P., Gaudebout, C., Certain, A., Bove, F. and Bowet, E., Dapsone-pyrimethamine compared with aerosolized pentamadine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.N. Engl. J. Med., 328, 1514–1520 (1993).
Gold, E. and Nankervis, G. A., Cytomegalovirus. In Evans AS (ed):Viral infections of humans: Epidemiology and Control, ed 2. New York, Plenum Press, pp 167 (1982).
Goodgame, R. W., Gastrointestinal Cytomegalovirus disease.Ann. Intern. Med., 119, 924–935 (1993).
Gottlieb, M. S., Schroff, R., and Schanker, H. M.,Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency.N. Engl. J. Med., 305, 1425–1431 (1981).
Grabill, J. R., Sobel, J., Saag, M., van der Horst, C., Powderly, W., Cloud, G., Riser, L., Hamill, R., Dismukes, W., and the NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups, diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis.Clin. Infect. Dis., 30, 47–54 (2000).
Grinsztejn, B., Fandinho, F. C. O., Veloso, V. G., Joao, E. C., Lourenco, M. C. S., Nogueira, S. A., Fonseca, L. S. and Werneck-Barroso, E., Mycobacteremia in patients with the acquired immunodeficiency syndrome.Arch. Intern. Med., 157, 2359–2363 (1997).
Gruden, J. F., Huang, L., Turner, J., Webb, W. R., Merrifield, C., Stansell, J. D., Gamsu, G., and Hopewell, P. C., High resolution CT in the evaluation of clinically suspectedPneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings.Am. J. Roengenol., 169, 967–975 (1997).
Hauser, W. E., Luft, B. J., Conley, F. K. and Remington, J. S., Central nervous system toxoplasmosis in homosexual and heterosexual adults.N. Engl. J. Med., 307, 498–499 (1982).
Havlik, J. A., Horsburgh, C. R., Mechock, B., Williams, P. P., Fann, S. A., and Thompson, S. E., DisseminatedMycobacterium avium complex infection: clinical identification and epidemiologic trends.J. Infect. Dis., 165, 577–580 (1992).
Havlir, D. V., Dube, M. P., Sattler, F. R., Forthal, D. N., Kemper, C. A., Dunne, M. W., Parenti, D. M., Lavelle, J. P., White, A. C., Witt, M. D., Bozzette, S. A. and McCutchan, J.A., for the California Collaborative Treatment Group, prophylaxis against disseminatedMycobacterium avium complex with weekly azithromycin, daily rifabutin, or both.N. Engl. J. Med., 335, 392–398 (1996).
Havlir, D. and Ellner, J.,Mycobacterium avium Complex., In Mandell, Bennett, and Dolin (ed),Principles and Practices of Infectious Diseases, Churchill Livingston, Philadelphia, pp. 2616–2625 (2000).
Helweg-Larsen, J., Tsolaki, A. G., Miller, R. F., Lundgren, B. and Wakefield, A.E., Clusters ofPneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping.Q. J. M., 91, 813–820 (1998).
Holland, G. N., Tufail, A. and Jordan, M.C., Cytomegalovirus diseases. In Pepose J. S., Holland G. N., and Wilhelmus K. R. (eds):Ocular infection and immunity. St. Louis, CV Mosby Company p. 1088 (1996).
Horsburgh, C. R.,Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.N. Engl. J. Med., 324, 1332–1338 (1991).
Horsburgh, C. R., Chin, D. P., Yajko, D. M., Hopewell, P. C., Nassos, P. S., Elkin, E. P., Hadley, W. K., Stone, E. N., Simon, E. M., Gonzalez, P., Ostroff, S. and Reingold, A. L., Environmental risk factors for acquisition ofMycobacterium avium complex in persons with human immunodeficiency virus infection.J. Infect. Dis., 170, 362–367 (1994).
Horsburgh, C.R., Epidemiology ofMycobacterium avium Complex Disease. In John Phair & Lowell Young (ed) Clinical Challenges ofMycobacterium avium. Am. J. Med., 102(5C) pp. 11–15, (1997).
Hughes, W. T.Pneumocystis carinii pneumonia.N. Engl. J. Med., 297, 1381–1383 (1977).
Hughes, W., Lwoung, G., Kramer, F., Bozette, S. A., Safrin, S., Frame, P., Clumeck, N., Masur, H., Lancaster, D., Chan, C., Lavelle, J., Rosenstock, J., Falloon, J., Feinberg, J., LaFon, S., Rogers, M. and Sattler, F., Comparison of atovaquone with trimethoprim-sulfamethoxazole to treatPneumocystis carinii pneumonia in patients with AIDS.N. Engl. J. Med., 328, 1521–1527 (1993).
Jacobson, J. M., Hafner, R., Remington, J., Farthing, C., Holden-Wiltse, J., Bosler, E. M., Harris, C., Jayaweera, D. J., Roque, C. and Luft, B. J., Dose-escalation, phase l/ll study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.AIDS, 15, 583–589 (2001).
Jacobson, M. A. Cytomegalovirus. In Dolin R., Masur H., and Saag MS (ed),AIDS Therapy. Churchill Livingstone, Philadelphia. pp 456–471 (1999).
Kales, C. P., Murren, J. R., Torres, R. A. and Crocco, J. A., Early predictors of in-hospital mortality forPneumocystis carinii pneumonia in acquired immunodeficiency syndrome.Arch. Intern. Med., 147, 1413–1417 (1987).
Katlama, C., De Wit, S., Odoherty, E., Van Glabeke, M. and Clumeck, N., Pyrimethamine-clindamycin vs pyrimethamine- sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.Clin. Infect. Dis., 22, 268–275 (1996).
Kemper, C. A., Treatment ofMycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen: rifampin, ethambutol, clofazimine, and ciprofloxacin.Ann. Intern. Med., 116, 466–472 (1992).
Kilby, J. M., Marques, M. B., Jaye, D. L., Tabereaux, P. B., Reddy, V. B. and Waites, K. B., The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.Am. J. Med., 104, 123–128 (1998).
Koletar, S. L., Treatment ofMycobacterium avium in human immunodeficiency virus-infected individuals, In Clinical Challenges of Mycobacterium avium.Am. J. Med., 102(5C), pp. 16–21 (1997).
Korvick, J. A.,Mycobacterium avium Complex. In Yu, Merigan, and Barriere, (eds)Antimicrobial Therapy and Vaccines, Williams & Wilkins, Baltimore, pp. 497–508 (1999).
Kravcik, S., Hawley-Foss, N., Victor, G., Angel, J. B., Garber, G. E., Page, S., Denomne, N., OReilly, L. and Cameron, D. W., Causes of death of HIV infected persons in Ottawa, Ontario, 1984-1995.Arch. Intern. Med., 157, 2069–2073 (1997).
Lalezari, J. P., Stagg, R. J., Kuppermann, B. D., Holland, G. N., Kramer, F., Ives, D. V., Youle, M., Robinson, M. R., Drew, L. and Jaffe, H. S., Intravenous cidofovir for peripheral Cytomegalovirus retinitis in patients with AIDS a randomized, controlled trial.Ann. Intern. Med., 126, 257–263 (1997).
Ledergerber, B., Egger, M., Erard, V., Weber, R., Hirschel, B., Furrer, H., Battegay, M., Vernazza, P., Bernasconi, E., Opravil, M., Kaufmann, D., Sudre, P., Francioli, P., Telenti, A., AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy. The Swiss HIV cohort study.JAMA, 282, 2220–2226 (1999).
Levy, R. M., Mills, C. M., Posin, J. P., Moore, S. G., Rosenblum, M. L. and Bredesen, D. E., The efficacy and clinical impact of brain imaging in neurologically symptomatic AIDS patients: a prospective CT/MRI study.J. Acquir. Immune. Defic. Syndr., 3, 461–471 (1990).
Lorberboym, M., Wallach, F., Estok, L., Mosesson, R. E., Sacher, M., Kim, C. K. and Machac, J., Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and non-malignant lesions in AIDS patients.J. Nucl. Med., 39, 1366–1369 (1998).
Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D. 3rd, Uttamchandani, R., Fuhrer, J. and Jacobson, J., Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.N. Engl. J. Med., 329, 995–1000 (1993).
Lunseth, J. H., Kirmse, T. W., Prezyna, A. P. and Gerth, R. E., Interstitial plasma cell pneumonia.J. Pediatr., 46, 137–145 (1955).
Masur, H., Michelis, M. A. and Greene, J.B., An outbreak of community-acquiredPneumocystis carinii pneumonia. Initial manifestation of cellular immune dysfunction.N. Engl. J. Med., 305, 1431–1438 (1981).
McCutchan, J. A., Cytomegalovirus infections of the nervous system in patients with AIDS.Clin. Infect. Dis., 20, 747–754 (1995).
McNeil, J. I. and Kan, V. L., Decline in the incidence of cryptococcosis among HIV-infected patients.J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 9, 206–208 (1995).
Montaner, J. S. G., Lawson, L. M., Levitt, N., Belzberg, A., Schechter, M. T and Ruedy, J., Corticosteroids prevent early deterioration in patients with moderately severePneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS).Ann. Intern. Med., 113, 14–20 (1990).
Montoya, J. G., Remington, J. S. Toxoplasma gondii. In:Principles and practice of infectious diseases, 5th ed. Mandell G. L., Bennett J. E. and Dolin R. (Eds). Churchill Livingston, Philadelphia. p. 2858 (2000).
Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., Kuppermann, B. D. and the ganciclovir implant study group. Treatment of Cytomegalovirus retinitis with a sustained release ganciclovir implant.N. Engl. J. Med., 337, 83–90 (1997).
National Institutes of Health-University of California expert panel for corticosteroids as adjunctive therapy for Pneumocystis pneumonia. Consensus statement on the use of corti- costeroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome.N. Engl. J. Med., 323, 1500–1504 (1990).
Nightingale, S. D., Byrd, L. T., Southern, P. M., Jockusch, J. D., Cal, S. X. and Wynne, B. A., Incidence ofMycobacterium avium-intracellulare complex infections bacteremia in human immunodeficiency virus-positive patients.J. Infect. Dis., 165, 1082–1085 (1992).
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., Holmberg, S. D., and the HIV Outpatient Study Investigators, declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.N. Engl. J. Med., 338, 853–860 (1998).
Peacock, K., Lewis, L. and Lavoie, S., Erosive mediastinal lymphadenitis associated withM. avium infection in a pediatric acquired immunodeficiency syndrome patient.Ped. Infectious Disease J., 19, 576–578 (2000).
Phair, J., Munoz, A., Detels, R., Kaslow, R., Rinaldo, C. and Saah, A., The risk ofPneumocystis carinii pneumonia among men infected with the human immunodeficiency virus type I. Multicenter AIDS cohort study group.N. Engl. J. Med., 322, 161–165 (1990).
Pierce, M., Crampton, S., Henry, D., Heifets, L., LaMarca, A., Montecalvo, M., Wormser, G., Jablonowski, H., Jemsek, J., Cynamon, M., Yangco, B., Notario, G., and Craft, J. C., A randomized trial of clarithromycin as prophylaxis against disseminatedMycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.N. Engl. J. Med., 335, 384–391 (1996).
Pifer, L. L., Hughes, W. T., Stango, S. and Woods, D.,Pneumocystis carinii infection: evidence of high prevalence in normal and immunosuppressed children.Pediatrics, 61, 35–41 (1978).
Porter, S. B. and Sande, M.A., Toxoplasmosis of the central nervous system in the acquired immunodeficiency syn- drome.N. Engl. J. Med., 327, 1643–1648 (1992).
Powderly, W. G., Cryptococcosis. In Dolin R., Masur H., and Saag M. S. (ed),AIDS Therapy. Churchill Livingstone, Philadelphia, pp 400–411 (1999).
Rabaud, C., May, T., Amiel, C., Katlama, C., Leport, C., Ambroise-Thons, P. and Canton, P., Extracerebral toxo- plasmosis in patients infected with HIV. A French national survey.Medicine, 73, 306–314 (1994).
Ribera, E., Fernandez-Sola, A., Juste, C., Rovira, A., Romero, F. J., Armadans-Gil, L., Ruiz, I., Ocana, I. and Pahissa, A., Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.Clin. Infect. Dis., 29, 1461–1466 (1999).
Rigsby, M. O., and Curtis, A. M., Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus.Chest, 106, 913–919 (1994).
Rozenbaum, R. and Goncalves, A. J. R., Clinical epi- demiological study of 171 cases of cryptococcosis.Clin. Infect. Dis., 18, 369–380 (1994).
Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, M. H., Sharkey, P. K., Thompson, S. E., Sugar, A. M., Tuazon, C. U., Fisher, J. F., Hyslop, N., Jacobson, J. M., Hafner, R., Dismukes, W. E., and the NIAID Mycoses Study Group and the AIDS Clinical Trials Group, comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis.N. Engl. J. Med. 326, 83–89 (1992).
Saag, M. S., Graybill, R. J., Larsen, R. A., Pappas, P. G., Perfect, J. R., Powderly, W. G., Sobel, J. D. and Dismukes, W. E., for the Mycoses Study Group Cryptococcal Subproject, practice guidelines for the management of cryptococcal disease.Clin. Infect. Dis., 30, 710–718 (2000).
Sabin, A. B., Toxoplasmic encephalitis in children.JAMA, 116, 801–807 (1941).
Sacktor, N., Lyles, R. H., Skolasky, R., Kleeberger, C., Seines, O. A., Miller, E. N., Becker, J. T., Cohen, B. and Mcarthur, J. C., HIV-associated neurologic disease incidence changes: Multicenter AIDS cohort study. 1990-1998.Neurology, 56, 257–260 (2001).
Safrin, S., Finkelstein, D. M., Feinberg, J., Frame, P., Simpson, G., Wu, A., Cheung, T., Soeiro, R., Hojczyk, P. and Black, J. R., Comparison of three regimens for the treatment of mild to moderatePneumocystis carinii Pneumonia in patients with AIDS A double blind, randomized trial of oral trimethoprim sulfamethoxazole, dapsone-trimethoprim and clindamycin- primaquine.Ann. Intern. Med., 124, 792–802 (1996).
Selik, R. M., Chu, S. Y. and Ward, J. W., Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992.Ann. Intern. Med., 123, 933–936 (1995).
Sepkowitz, K. A., Telzak, E. E., Gold, J. W. M., Bernard, E. M., Blum, S., Carrow, M., Dickmeyer, M. and Armstrong, D., Pneumothorax in AIDS.Ann. Intern. Med., 114, 455–459 (1991).
Shafran, S. T., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, J., Rachlis, A. R., Lalonde, R. G., Fanning, M. M., and Tsoukas, C., for the Canadian HIV Trials Network Protocol 010 Study Group, A comparison of two regimens for the treatment ofMycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin.N. Engl. J. Med., 335, 377–383 (1996).
Spector, S. A., McKinley, G. F., Lalezari, J. P., Samo, T., Andruczk, R., Follansbee, S., Spartl, P. D., Havlir, D. V., Simpson, G., Buhles, W., Wong, R. and Stempien, M. J., For the Roche cooperative oral ganciclovir study group. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS.N. Engl. J. Med., 334, 1491–1497 (1996).
So, Y. T. and Olney, R. K., Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients.Ann. Neurol., 35, 53–58 (1994).
Stansell, J. D., Osmond, D. H., Charlebois, E., Lavange, L., Wallace, J. M., Alexander, B. V., Glassroth, J., Kvale, P. A., Rosen, M. J., Reichman, L. B., Turner, J. R. and Hopewell, P. C., Predictors ofPneumocystis carinii pneumonia in HIV infected persons.Am. J. Respir. Crit. Care. Med., 155, 60–66 (1997).
Stover, D. E. and Meduri, G. U., Pulmonary function tests.Clin. Chest. Med., 9, 473–479 (1988).
Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcomes in patients with AIDS and CMV retinitis treated with either foscamet or ganciclovir.J. Infect. Dis., 176, 50–58 (1997).
Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed Cytomegalovirus retinitis in patients with AIDS.Arch. Ophthalmol., 114, 23–33 (1996).
Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trials Group., Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial.Ann. Intern. Med., 126, 264–274 (1997).
Tietjen. P. A., Clinical presentation and diagnosis ofPneumocystis carinii infection in HIV-infected patients. UpToDate www.uptodate.com (2001).
Toma, E., Fournier, S., Dumont, M., Bolduc, P. and Deschamps, H., Clindamycin/primaquine versus trimethoprim sulfame- thoxazole as primary therapy forPneumocystis carinii pneumonia in AIDS: A Randomized, double blind Pilot trial.Clin. Infect. Dis., 17, 178–184 (1993).
Toma, E., Thome, A., Singer, J., Raboud, J., Lemieux, C., Trottier, S., Bergeron, M. G., Tsoukas, C., Falutz, J., Lalonde, R., Gaundreau, C., Therrien, R., and the CTN-PCP Study group. Clindamycin with primaquine vs trimethoprim sulfa- methoxazole therapy for mild and moderately severePneumocystis carinii pneumonia in patients with AIDS: A multicenter, double blind randomized trial (CTN 004).Clin. Infect. Dis., 27, 524–530 (1998).
Torres, J., Goldman, M., Wheat, L. J., Tang, X., Bartlett, M. S., Smith, J. W., Allen, S. D. and Lee, C. H., Diagnosis ofPneumocystis carinii pneumonia in human immunodeficiency virus infected patients with polymerase chain reaction: a blinded comparison to standard methods.Clin. Infect. Dis., 30, 141–145 (2000).
Torres, R. A., Weinberg, W., Stansell, J., Leoung, G., Kovacs, J., Rogers, M. and Scott, J., Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group.Clin. Infect. Dis., 24, 422–29 (1997).
Uberti-Foppa, C., Lillo, F., Terreni, M. R., Puglisi, A., Guffanti, M., Gianotti, N. and Lazzarin, A., Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus cultures from BAL fluid and correlation with lung disease.Chest, 113, 919–923 (1998).
United States Public Health Service/Infectious Diseases Society of America Prevention of Opportunistic Infections Working Group, “Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (Draft),” available at www.hivatis.com, July 2001.
Van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moscovitz, B. L., Powderly, W. G., and Dismukes, W.E., for the Mycoses Study Group and AIDS Clinical Trials Group, treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.N. Engl. J. Med., 337, 15–21 (1997).
Vilaseca, J., Arnau, J.M., Bacardi, R., Mieras, C., Serrano, A., Navarro, C. Kaposis sarcoma and Toxoplasma gondii brain abscess in a Spanish homosexual.Lancet, 1, 572 (1982).
Von Reyn, C. F., Barber, T. W., Arbeit, R. D., Sox, C. H., O’Connor, G. T., Brindle, R. J., Gilks, C. F., Ranki, A., Hakkarainen, K., Bartholomew, C., Edwards, J., Tosteson, A. N. A. and Magnusson, M., Evidence of previous infection withMycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.J. Infect. Dis., 168, 1553–1558 (1993).
Whitcup, S. M., Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.JAMA, 283, 653–657 (2000).
Whitley, R. J., Jacobson, M. A., Friedberg, D. N., Holland, G. N., Jabs, D. A., Dietrich, D. T., Hardy, W. D., Polis, M. A., Deutsch, T. A., Feinberg, J., Spector, S. A., Walmsley, S., Drew, W. L., Powderly, W. G., Griffiths, P. D., Benson, C. A., Kessler, H. A. for the international AIDS society-USA. Guidelines for the treatment of Cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Recommendations of an international panel.Arch. Intern. Med., 158, 957–969 (1998).
Woods, M. L., MacGinley, R., Eisen, D. P. and Allworth, A. M., HIV combination therapy: partial immune restitution un- masking latent cryptococcal infection.AIDS, 12, 1491–1494 (1998).
Zakowski, P., Fligiel, S., Berlin, O. G. W. and Johnson, B.L., DisseminatedMycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency.JAMA, 248, 2980–2982 (1982).
Zaman, M. K. and White, D. A., Serum lactate dehydrogenase levels andPneumocystis carinii pneumonia: diagnostic and prognostic significance.Am. Rev. Respir. Dis., 137, 796–800 (1988).
Zaman, M. K., Wooten, O. J., Suprahmanya, B., Ankobiah, W., Finch, P. J., Kamholz, S. L. Rapid non-invasive diagnosis ofPneumocystis carinii from induced liquefied sputum.Ann. Intern. Med., 109, 7–10 (1988).
Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. and Rahal, J. J., Cryptococcal disease in patients with acquired immunodeficiency syndrome.Ann. Intern. Med., 104, 234–240 (1986).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Samuel, R., Bettiker, R.L. & Suh, B. AIDS related opportunistic infections, going but not gone. Arch Pharm Res 25, 215–228 (2002). https://doi.org/10.1007/BF02976619
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976619